SMPD3 and Alzheimer disease: GW4869, an inhibitor of nSMase2, was shown to reduce Aβ in a mouse model of AD by preventing the secretion of exosomes, thus indicating that the ceramide generated by nSMase2 may be critical for the formation of exosomes (Wang et al., 2012).